Abstract
Calcium pyrophosphate dihydrate (CPPD) crystal deposition disease is a well-recognized inflammatory joint disorder. Extensor tendon rupture associated with CPPD deposition has rarely been described. We report herein the case of a 58-year-old woman who underwent reconstruction for subcutaneous extensor tendon ruptures of the extensor tendons for the ring and little fingers on both wrists associated with CPPD deposition. The significance of this case is the occurrence at an earlier age compared to previous papers and the appearance on bilateral wrists.
Similar content being viewed by others
References
L Sauve M Kapandji (1936) ArticleTitleNouvelle technique de traitement chirurgical des luxation rechidivantes isolee de l'extremite inferieur du cubitus J Chir 47 589–94
DJ McCarty NN Kohn JS Faires (1962) ArticleTitleThe significance of calcium phosphate crystals in the synovial fluid of arthritic patients: the “pseudogout syndrome”. I. Clinical aspects Ann Intern Med 56 711–37 Occurrence Handle1:CAS:528:DyaF38XksFagsLk%3D
DJ McCarty (1976) ArticleTitleCalcium pyrophosphate dehydrate crystal deposition disease Arthritis Rheum 19 275–85 Occurrence Handle181010 Occurrence Handle10.1002/1529-0131(197605/06)19:3+<275::AID-ART1780190702>3.0.CO;2-0
D Resnick G Niwayama TG Goergen PD Utsinger RF Shapiro DH Haselwood KB Wiesner (1977) ArticleTitleClinical, radiographic and pathologic abnormalities in calcium pyrophosphate deposition disease (CPPD): pseudogout Radiology 122 1–15 Occurrence Handle186841 Occurrence Handle1:STN:280:CSiD2MfotFI%3D
D Resnick G Niwayama (1977) ArticleTitleCapital instability in rheumatoid arthritis and calcium pyrophosphatevdeposition disease. Pathogenesis and roentgen appearance Ann Rheum Dis 36 311–8 Occurrence Handle901029 Occurrence Handle1:STN:280:CSiB28rmsF0%3D
RL Smathers CB Stellin TE Kears (1982) ArticleTitleThe destructive wrist arthropathy of pseudogout Skelet Radiol 7 255–8 Occurrence Handle10.1007/BF00361981 Occurrence Handle1:STN:280:Bi2C2snjt1Q%3D
AI Blinder MN Sheppard E Parice (1989) ArticleTitleExtensor tendon rupture related to calcium pyrophosphate crystal deposition disease Br J Rheumatol 28 251–3 Occurrence Handle10.1093/rheumatology/28.3.251
D Van Linthoudt C Gabay H Otto (1989) ArticleTitleExtensor tendon rupture related to calcium pyrophosphate crystal deposition disease Br J Rheumatol 28 552–3 Occurrence Handle2556208 Occurrence Handle10.1093/rheumatology/28.6.552 Occurrence Handle1:STN:280:By%2BD2svptlM%3D
C Zenklusen JY Alnot L Bocquet MF Kahn (1989) ArticleTitleCase report. Extensor tendon rupture related to destructive change of the inferior radio-ulnar joint: a newly recognized manifestation of chondrocalcinosis J Orthop Rheumatol 2 235–40
A Jones N Barton M Pattrick M Doherty (1992) ArticleTitleTophaceous pyrophosphate deposition with extensor tendon rupture Br J Rheumatol 31 421–3 Occurrence Handle1596707 Occurrence Handle10.1093/rheumatology/31.6.421 Occurrence Handle1:STN:280:By2B1c3jslY%3D
Y Taniguchi M Yoshida T Tamaki (1997) ArticleTitleSubcutaneous extensor tendon rupture associated with calcium pyrophosphate dehydrate crystal deposition disease of wrist J Hand Surg [Br] 22 386–7 Occurrence Handle10.1016/S0266-7681(97)80409-3 Occurrence Handle1:STN:280:ByiA28nhtFA%3D
Y Waguri-Nagaya Y Kokubo I Sekiya T Otsuka I Shiomi H Shimizu et al. (2002) ArticleTitleExtensor tendon rupture related to calcium pyrophosphate crystal deposition disease Rheumatol Int 21 243–6 Occurrence Handle12036212 Occurrence Handle10.1007/s00296-002-0176-0 Occurrence Handle1:STN:280:DC%2BD383psFGlsA%3D%3D
R Terkeltaub C Zachariae D Santoro J Martin P Peveri K Matsushima (1991) ArticleTitleMonocyte-derived neutrophil chemotactic factor/interleukin-8 is a potential mediator of crystal-induced inflammation Arthritis Rheum 34 894–903 Occurrence Handle2059236 Occurrence Handle10.1002/art.1780340716 Occurrence Handle1:CAS:528:DyaK38XlslWlsg%3D%3D
FS di Giovine SE Malawista E Thornton GW Duff (1991) ArticleTitleUrate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution J Clin Invest 87 1375–81 Occurrence Handle2010550 Occurrence Handle1:CAS:528:DyaK3MXitVGhurs%3D Occurrence Handle10.1172/JCI115142
R Liu-Bryan F Liote (2005) ArticleTitleMonosodium urate and calcium pyrophosphate dihydrate (CPPD) crystals, inflammation, and cellular signaling Joint Bone Spine 72 295–302 Occurrence Handle15990350 Occurrence Handle10.1016/j.jbspin.2004.12.010
R Liu M O'Connell K Johnson K Pritzker N Mackman R Terkeltaub (2000) ArticleTitleExtracellular signal-regulated kinase 1/extracellular signal-regulated kinase 2 mitogen-activated protein kinase signaling and activation of activator protein 1 and nuclear factor kappaB transcription factors play central roles in interleukin-8 expression stimulated by monosodium urate monohydrate and calcium pyrophosphate crystals in monocytic cells Arthritis Rheum 43 1145–55 Occurrence Handle10817569 Occurrence Handle10.1002/1529-0131(200005)43:5<1145::AID-ANR25>3.0.CO;2-T Occurrence Handle1:CAS:528:DC%2BD3cXjvVeiurc%3D
R Liu F Liote DM Rose D Merz R Terkeltaub (2004) ArticleTitleProline-rich tyrosine kinase 2 and Src kinase signaling transduce monosodium urate crystal-induced nitric oxide production and matrix metalloproteinase 3 expression in chondrocytes Arthritis Rheum 50 247–58 Occurrence Handle14730623 Occurrence Handle10.1002/art.11486 Occurrence Handle1:CAS:528:DC%2BD2cXht1Kqsr0%3D
PE Lipsky DM van der Heijde EW St Clair DE Furst FC Breedveld JR Kalden et al. (2000) ArticleTitleInfliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group N Engl J Med 343 1594–602 Occurrence Handle11096166 Occurrence Handle10.1056/NEJM200011303432202 Occurrence Handle1:CAS:528:DC%2BD3cXovVeltLk%3D
R Maini EW St Clair F Breedveld D Furst J Kalden M Weisman et al. (1999) ArticleTitleInfliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group Lancet 354 1932–9 Occurrence Handle10622295 Occurrence Handle10.1016/S0140-6736(99)05246-0 Occurrence Handle1:CAS:528:DC%2BD3cXit1Oquw%3D%3D
ME Weinblatt JM Kremer AD Bankhurst KJ Bulpitt RM Fleischmann RI Fox et al. (1999) ArticleTitleA trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate N Engl J Med 340 253–9 Occurrence Handle9920948 Occurrence Handle10.1056/NEJM199901283400401 Occurrence Handle1:CAS:528:DyaK1MXht1Wqsbk%3D
PJ Mease AJ Kivitz FX Burch EL Siegel SB Cohen P Ory et al. (2004) ArticleTitleEtanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression Arthritis Rheum 50 2264–72 Occurrence Handle15248226 Occurrence Handle10.1002/art.20335 Occurrence Handle1:CAS:528:DC%2BD2cXmsVansbc%3D
CE Antoni A Kavanaugh B Kirkham Z Tutuncu GR Burmester U Schneider et al. (2005) ArticleTitleSustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT) Arthritis Rheum 52 1227–36 Occurrence Handle15818699 Occurrence Handle10.1002/art.20967 Occurrence Handle1:CAS:528:DC%2BD2MXktFCktbw%3D
J Hirose LM Ryan I Masuda (2002) ArticleTitleUp-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease Arthritis Rheum 46 3218–29 Occurrence Handle12483726 Occurrence Handle10.1002/art.10632 Occurrence Handle1:CAS:528:DC%2BD3sXjslGitw%3D%3D
W Darrach (1912) ArticleTitleAnterior dislocation of the head of the ulna Ann Surg 56 802–3
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Ariyoshi, D., Imai, K., Yamamoto, S. et al. Subcutaneous tendon rupture of extensor tendons on bilateral wrists associated with calcium pyrophosphate dihydrate crystal deposition disease. Mod Rheumatol 17, 348–351 (2007). https://doi.org/10.1007/s10165-007-0598-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10165-007-0598-3